Navigation Links
Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication
Date:11/25/2008

FRAZER, Pa. and LONDON, Nov. 25 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) and ImmuPharma PLC (LSE: IMM), a European pharmaceutical company, today announced that the companies have signed an Option Agreement providing Cephalon with an option to obtain an exclusive, worldwide license to the investigational medication Lupuzor(TM) for the treatment of Systemic Lupus Erythematosus. ImmuPharma is now conducting a large Phase IIb study of Lupuzor in patients in Europe and Latin America.

Under the terms of the option agreement, Cephalon will pay ImmuPharma a $15 million upfront option payment. If the Phase IIb studies are successful and if the option is exercised then the parties enter into an exclusive worldwide license agreement and ImmuPharma will receive a one-time license fee, milestone payments upon the achievement of regulatory milestones and royalties on commercial sales of Lupuzor. The various milestone payments which include sales milestones may total up to $500 million. Upon exercise of the option, Cephalon will assume all expenses for Phase III studies and subsequent commercialization of the product.

"We are excited about entering another specialty market and the potential Lupuzor presents for us to further diversify our product portfolio and to bring the first specific medication for the treatment of lupus to patients living with this chronic, potentially life-threatening disease," said Frank Baldino, Jr., Ph.D. chairman and CEO of Cephalon. "Our current cash position has created the opportunity to make this type of deal, which helps to position Cephalon and our pipeline for longer term growth."

"We are truly delighted to have this agreement with Cephalon and believe they would be a great partner to take Lupuzor forward. It represents an important landmark for the company and secur
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Video: Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkins Lymphoma
2. Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkins Lymphoma
3. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
4. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
5. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
6. Cephalon Conference Call Invitation
7. Cephalon Reports Strong First Quarter Earnings
8. Cephalon Appoints Gerald J. Pappert as General Counsel
9. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
10. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
11. Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... York, NY (PRWEB) July 23, 2014 ... 2 billion dollars by the year 2020, according to ... skin are among the top sellers in the U.S. ... The best wrinkle cream under $100 is now reviewed ... meant to help a first-time or experienced shopper to ...
(Date:7/23/2014)... July 23, 2014 The puffiness that ... using non-surgical techniques, according to a new guide published ... serum sold in the U.S. is now available for ... , The complimentary guide that is now published is ... with under eye puffiness. While surgical techniques are available, ...
(Date:7/23/2014)... has developed a simple, cheap and highly accurate ... which attacks immune deficient individuals such as cancer ... lateral-flow device (LFD), created by Professor Chris Thornton, ... diagnose disease caused by the fungus Aspergillus ... a leading cause of death in acute leukaemia ...
(Date:7/23/2014)... Randy Dotinga HealthDay Reporter ... A powerful drug combo may not be as effective ... on human cells suggests that one of the medications ... this study,s findings aren,t definitive, and there,s still hope ... and lumacaftor, according to the study,s senior author. ...
(Date:7/23/2014)... AB (PRWEB) July 23, 2014 ... of in-home care for seniors, is proud to announce ... Series featuring experts in a wide range of health ... clinical social worker and award-winning author Nancy Kriseman, and ... and ways to prevent burnout by becoming more self-aware. ...
Breaking Medicine News(10 mins):Health News:Best Wrinkle Cream Under $100 Reviewed at Top News Website Online 2Health News:Puffy Eyes Serum Explored in Complimentary Guide Released at Consumer News Website 2Health News:New device detects deadly lung disease 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3
... it,s no better than standard treatment, one expert says, ... the indigestion and heartburn that bother many women as ... Indigestion is common during pregnancy, with up to 80 ... reflux, belching and bloating. Symptoms tend to worsen over ...
... - Europe Cosmetiques and Probiox announced today that both ... respect to oxidative stress profiling. Under this agreement, Europe ... and Mexico. , According to Manon Pilon, Founder President ... the leader in the Medical SPA industry, and is ...
... PEMBROKE, Bermuda, June 9 Allied World ... Assurance Company,Holdings, Ltd (NYSE: AWH ), today ... product offered in the United States. The,complimentary service, called ... crisis management resources in the,event of a catastrophe. , ...
... Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today ... trial of sodium oxybate (JZP-6) for the treatment of ... Professional Sleep Societies (APSS) 2009 Annual Meeting in Seattle, ... (EULAR) Congress in Copenhagen, Denmark. , , Following ...
... Programs Designed to Address High Risks for New Dialysis Patients ... , DENVER, June 9 DaVita Inc. (NYSE: ... those diagnosed with chronic kidney disease (CKD), today commended Kidney ... Kidney Care (PEAK) campaign. Kidney Care Partners - a ...
... New techniques bring equivalent results without the potential dangers, ... Researchers say they,ve developed new techniques for reducing ... disease. , The use of these radiation-lowering strategies did ... computed tomography angiography (CCTA), an increasingly popular weapon in ...
Cached Medicine News:Health News: Acupuncture May Relieve Heartburn In Pregnancy 2Health News: Acupuncture May Relieve Heartburn In Pregnancy 3Health News:"Alliance between Europe Cosmetiques and Probiox brings new oxydative stress profiling technologies to North America" 2Health News:Allied World U.S. Announces Strategic Response(SM) - Complimentary Service Added to General Liability Lead Umbrella Product 2Health News:Allied World U.S. Announces Strategic Response(SM) - Complimentary Service Added to General Liability Lead Umbrella Product 3Health News:Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia 2Health News:Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia 3Health News:Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia 4Health News:DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 2Health News:DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 3Health News:Reduced-Radiation Heart Scans Don't Compromise on Quality 2
(Date:7/23/2014)... 23, 2014 Research and Markets ... Gloves (Exam and Surgical) Markets Worldwide 2014" report ... The purpose of this report is ... Medical (Exam and Surgical) Gloves. The report discusses key ... products. Topics covered include product definitions, strategies, ...
(Date:7/23/2014)... WASHINGTON , July 23, 2014  Nearly 8,000 ... for Cardinal Health,s annual Retail Business Conference (RBC), ... & Convention Center. This year,s event encourages pharmacists to ... in their communities and for their future. ... pharmacy owners to network with their peers and learn ...
(Date:7/23/2014)... , July 23, 2014  The management team ... ) will hold a conference call on July ... second quarter ended June 30, 2014.  The call ... 2014Time: , 8:30 am EDTDial-in numbers: , Toll ... (412) 317-0790Webcast (live & archive): , www.columbialabs.com ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: